Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Shattuck Labs Announces Participation in Upcoming March Conferences | ||
By: GlobeNewswire - 26 Feb 2024 | Back to overview list |
|
AUSTIN, TX and DURHAM, NC, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced that company management will participate in multiple investor conferences in March 2024. Presentation Details
Conference: Leerink Partners Global Biopharma Conference 2024 Conference: Citi's Biotech C-Suite Fireside Chat Series
A live webcast of the presentations will be available on the Investors section of the Company’s website. A replay of the webcast will be archived for up to 30 days following the presentation date. About Shattuck Labs, Inc. Investor & Media Contact:
|
||
|
||
Copyright 2024 GlobeNewswire | Back to overview list |